Alterity Therapeutics (ATH.AX) Earnings Analysis
Alterity Therapeutics (ATH.AX) next reports earnings on 2026-08-28, consensus EPS -0.01564 AUD. Last quarter (2026-02-25) it missed with EPS -0.0009 AUD vs -0.00057 AUD est (-57.9%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -7.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ATH.AX next report earnings?
| Next earnings date | 2026-08-28 |
|---|---|
| Consensus EPS estimate | -0.01564 AUD |
| Revenue estimate | 0.00B |
ATH.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.0009 AUD | -0.00057 AUD | -57.9% | Miss |
| 2025-08-28 | -0.0008 AUD | -0.00138 AUD | +42% | Beat |
| 2025-08-04 | -0.0014 AUD | -0.00171 AUD | +18.1% | Beat |
| 2024-08-29 | -0.1 AUD | -0.00016 AUD | -62400% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
ATH.AX valuation and analyst view
| Trailing P/E | -7.01 |
|---|---|
| Trailing EPS | -0.07166 AUD |
| Price / book | 2.16 |
| Dividend yield | 0.00% |
| Market cap | 0.12B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Alterity Therapeutics (ATH.AX)'s next earnings date?
Alterity Therapeutics is next scheduled to report on 2026-08-28, with a consensus EPS estimate of -0.01564 AUD and revenue estimate of 0.00B.
Did ATH.AX beat earnings last quarter?
In its 2026-02-25 report, ATH.AX posted EPS of -0.0009 AUD versus a -0.00057 AUD estimate — a miss of 57.9%.
What is ATH.AX's earnings track record?
Over the last 4 reported quarters with consensus data, ATH.AX beat estimates 2 times (50%).
What is ATH.AX's current P/E ratio and EPS?
ATH.AX trades at a trailing P/E of -7.01 on trailing EPS of -0.07166404471150019 AUD.
What do analysts rate ATH.AX?
ATH.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.